Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dss (DSS) EBITDA (2016 - 2023)

Dss has reported EBITDA over the past 14 years, most recently at -$5.6 million for Q1 2023.

  • For Q1 2023, EBITDA rose 23.76% year-over-year to -$5.6 million; the TTM value through Mar 2023 reached -$28.9 million, down 5.19%, while the annual FY2025 figure was -$14.4 million, 66.11% up from the prior year.
  • EBITDA for Q1 2023 was -$5.6 million at Dss, down from $2.1 million in the prior quarter.
  • Over five years, EBITDA peaked at $4.9 million in Q3 2020 and troughed at -$14.2 million in Q3 2022.
  • A 5-year average of -$3.6 million and a median of -$2.0 million in 2020 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: soared 495.04% in 2020 and later tumbled 1057.76% in 2021.
  • Year by year, EBITDA stood at -$157000.0 in 2019, then plummeted by 314.65% to -$651000.0 in 2020, then tumbled by 1057.76% to -$7.5 million in 2021, then skyrocketed by 127.38% to $2.1 million in 2022, then plummeted by 370.35% to -$5.6 million in 2023.
  • Business Quant data shows EBITDA for DSS at -$5.6 million in Q1 2023, $2.1 million in Q4 2022, and -$14.2 million in Q3 2022.